Julie Lindgård Graversen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Julie Lindgård Graversen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Annika Vestergaard Kvist
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.
3 shared publications - Johan Røikjer
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark
3 shared publications - Mia Daugaard Madsen
Steno Diabetes Center North Denmark, Aalborg University Hospital, Hospitalsbyen 4, 9260 Gistrup, Denmark; Department of Clinical Medicine, Aalborg University, Selma Lagerloefs Vej 249, 9260 Gistrup, Denmark
3 shared publications - Nicklas Højgaard Rasmussen
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark
3 shared publications - Peter Vestergaard
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark
3 shared publications - Marie Balle Sjogaard
Department of Biomedicine, Aarhus University, Aarhus, Denmark
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 242
Impaired muscle quality and physical performance in diabetic neuropathy: associations with skeletal characteristics from the Deep Phenotyping Study
- 12 October 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 242
Open AccessImpaired muscle quality and physical performance in diabetic neuropathy: associations with skeletal characteristics from the Deep Phenotyping Study
- Open Access
- 1 May 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 236, 113289
Postural control in type 2 diabetes mellitus: the role of diabetic neuropathy
- 1 May 2026
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 236, 113289
Open AccessPostural control in type 2 diabetes mellitus: the role of diabetic neuropathy
- Open Access
- 6 January 2022
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 21, 104-116
Prevalence and predictors of adequate treatment of overt hypothyroidism – a population-based study
The aim of this study is to evaluate the adequacy of treatment, and to identify factors influencing treatment of hypothyroidism. Patients newly diagnosed with overt hypothyroidism (n=345) were identified via a register linked to a laboratory database. In selected periods with staff available, 165 patients were invited, and 113 (68.5 %) accepted participating in a comprehensive program including blood tests and completion of questionnaires. We performed a longitudinal follow-up on thyroid function tests 10 years after the diagnosis. Time to reach a serum TSH level of 0.2-10 mU/L (termed as clinically acceptable) and biochemical normalization (TSH: 0.2-5.0 mU/L), respectively, were analyzed using Kaplan Meier survival analysis. Predictors for longer duration to reach the normal TSH range were identified using cox proportional hazards regression. Only 67.7 % of the patients were in the euthyroid range on the long term after diagnosis of overt hypothyroidism (2 years: 59.4 %; 10 years: 67.7 %). Median time to the first normal TSH was 8.9 months (95 % CI: 7.6-10.2 months). The factors associated with longer duration until normalization of TSH after multivariate analysis were age (HR 0.79 per 10 years; 95 % CI: 0.66-0.94; P = <0.01), smoking (HR 0.47; 95 % CI: 0.26-0.83; P = <0.01), serum TSH at diagnosis (HR 0.96 per 10 mU/L; 95 % CI: 0.93-0.99; P = 0.02) and BMI (HR 0.96 per kg/m2; 95 % CI: 0.91-0.99; P = 0.03). A considerable number of hypothyroid patients remained inadequately treated. When treating hypothyroid patients, special attention should be addressed to those patients who never or lately obtain euthyroid status.
- 6 January 2022
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 21, 104-116
Open AccessPrevalence and predictors of adequate treatment of overt hypothyroidism – a population-based study
The aim of this study is to evaluate the adequacy of treatment, and to identify factors influencing treatment of hypothyroidism. Patients newly diagnosed with overt hypothyroidism (n=345) were identified via a register linked to a laboratory database. In selected periods with staff available, 165 patients were invited, and 113 (68.5 %) accepted participating in a comprehensive program including blood tests and completion of questionnaires. We performed a longitudinal follow-up on thyroid function tests 10 years after the diagnosis. Time to reach a serum TSH level of 0.2-10 mU/L (termed as clinically acceptable) and biochemical normalization (TSH: 0.2-5.0 mU/L), respectively, were analyzed using Kaplan Meier survival analysis. Predictors for longer duration to reach the normal TSH range were identified using cox proportional hazards regression. Only 67.7 % of the patients were in the euthyroid range on the long term after diagnosis of overt hypothyroidism (2 years: 59.4 %; 10 years: 67.7 %). Median time to the first normal TSH was 8.9 months (95 % CI: 7.6-10.2 months). The factors associated with longer duration until normalization of TSH after multivariate analysis were age (HR 0.79 per 10 years; 95 % CI: 0.66-0.94; P = <0.01), smoking (HR 0.47; 95 % CI: 0.26-0.83; P = <0.01), serum TSH at diagnosis (HR 0.96 per 10 mU/L; 95 % CI: 0.93-0.99; P = 0.02) and BMI (HR 0.96 per kg/m2; 95 % CI: 0.91-0.99; P = 0.03). A considerable number of hypothyroid patients remained inadequately treated. When treating hypothyroid patients, special attention should be addressed to those patients who never or lately obtain euthyroid status.